AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
September 20 2007 - 7:30AM
PR Newswire (US)
QUEBEC CITY, Sept. 20 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company
focused on endocrine therapy and oncology, today announced that its
President and CEO, David J. Mazzo, Ph.D., will present a Company
overview at the UBS Global Life Sciences Conference on Thursday,
September 27, 2007 at 10:00 a.m. Eastern, in the Ballroom E of the
Grand Hyatt Hotel in New York City. A live webcast of this
presentation will be available on AEterna Zentaris' website at
http://www.aeternazentaris.com/ in the Investors section. A replay
will also be available for a period of 30 days on the Company's
website. About AEterna Zentaris Inc. AEterna Zentaris Inc. is
global biopharmaceutical company focused on endocrine therapy and
oncology with proven expertise in drug discovery, development and
commercialization. News releases and additional information are
available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA
ZENTARIS INC. CONTACT: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475, ; Paul
Burroughs, Media Relations, (418) 652-8525 ext. 406,
Copyright